AU1465400A - Identification of inhibitors of the hgf-met-upa-plasmin network using a novel cellular assay - Google Patents

Identification of inhibitors of the hgf-met-upa-plasmin network using a novel cellular assay

Info

Publication number
AU1465400A
AU1465400A AU14654/00A AU1465400A AU1465400A AU 1465400 A AU1465400 A AU 1465400A AU 14654/00 A AU14654/00 A AU 14654/00A AU 1465400 A AU1465400 A AU 1465400A AU 1465400 A AU1465400 A AU 1465400A
Authority
AU
Australia
Prior art keywords
upa
hgf
inhibitors
met
identification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14654/00A
Inventor
Curtis D. Hose
Michael E. Jeffers
Anne Monks
George F Vande Woude
Craig P. Webb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
US Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Government filed Critical US Department of Health and Human Services
Publication of AU1465400A publication Critical patent/AU1465400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
AU14654/00A 1998-11-04 1999-11-03 Identification of inhibitors of the hgf-met-upa-plasmin network using a novel cellular assay Abandoned AU1465400A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10694498P 1998-11-04 1998-11-04
US60106944 1998-11-04
US13061399P 1999-04-22 1999-04-22
US60130613 1999-04-22
PCT/US1999/025910 WO2000025727A2 (en) 1998-11-04 1999-11-03 Use of flumethasone, fluocinolone acetonide fluoromethasone for manufacture of a medicament for the treatment of tumours

Publications (1)

Publication Number Publication Date
AU1465400A true AU1465400A (en) 2000-05-22

Family

ID=26804213

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14654/00A Abandoned AU1465400A (en) 1998-11-04 1999-11-03 Identification of inhibitors of the hgf-met-upa-plasmin network using a novel cellular assay

Country Status (2)

Country Link
AU (1) AU1465400A (en)
WO (1) WO2000025727A2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474765A (en) * 1992-03-23 1995-12-12 Ut Sw Medical Ctr At Dallas Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells
WO1994006909A2 (en) * 1992-09-18 1994-03-31 United States Of America, As Represented By The Secretary, Department Of Health And Human Services A method of preventing tumor metastasis
US5646136A (en) * 1994-01-04 1997-07-08 Duke University Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids
US5707624A (en) * 1994-06-03 1998-01-13 The Regents Of The University Of Michigan Treatment of Kaposi's sarcoma by inhibition of scatter factor

Also Published As

Publication number Publication date
WO2000025727A2 (en) 2000-05-11
WO2000025727A3 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
AU2001234128A1 (en) Novel imidazoline compounds
AU2042799A (en) Building block
AU6477498A (en) Scale inhibitors
AU6007699A (en) Showerhead
AU6041998A (en) Novel prostate-associated kallikrein
AU5991699A (en) Quinolizinones as integrin inhibitors
AU2623899A (en) Novel thiobenzamides
AU4723799A (en) Protease inhibitors
AU3616099A (en) Amine dispersants
AU6155899A (en) Novel pallets
AU7139598A (en) Protease inhibitors
AU2350199A (en) Novel aminoorganofunctionalsiloxanes
AU4092799A (en) Protease inhibitors
AU2016100A (en) New assay
AU1393900A (en) Morpholino-ethoxybenzofuran protease inhibitors
AU9110298A (en) Protease inhibitors
AU4037699A (en) Novel aryl-hydro naphthalenal kanamines
AU4564499A (en) Protease inhibitors
AU2713100A (en) Protease inhibitors
AU9300298A (en) Protease inhibitors
AU9158898A (en) Novel metalloprotease
AU2001232132A1 (en) Novel assay
AU1531801A (en) Novel assay
AU1381600A (en) Identification of senv genotypes
AU7537400A (en) Assay

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase